Skip to main content

Advertisement

Log in

Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 2007; 39: 425–429.

    Article  CAS  Google Scholar 

  2. Spanakis EK, Aperis G, Mylonakis E . New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clin Infect Dis 2006; 43: 1060–1082.

    Article  CAS  Google Scholar 

  3. Marr KA, Carter RA, Crippa F, Wald A, Corey L . Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909–917.

    Article  Google Scholar 

  4. Park BJ, Kontoyiannis DP, Pappas PG, Wannemuehler KA, Anaissie E, Fridkin SK et al. Comparison of Zygomycosis and fusariosis to invasive aspergillosis among transplant recipients reporting to TRANSNET [abstract M-666]. In: Program and Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (Washington). American Society for Microbiology: Washington, DC, 2004, p 411.

    Google Scholar 

  5. Marty FM, Cosimi LA, Baden LR . Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004; 350: 950–952.

    Article  CAS  Google Scholar 

  6. Siwek GT, Dodgson KJ, Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584–587.

    Article  Google Scholar 

  7. Chayakulkeeree M, Ghannoum MA, Perfect JR . Zygomycosis: the reemerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25: 215–229.

    Article  CAS  Google Scholar 

  8. Page RL, Schwiesow J, Hilts A . Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of literature. Pharmacotherapy 2007; 27: 290–298.

    Article  Google Scholar 

  9. Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335–347.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Ustun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ustun, C., Farrow, S., DeRemer, D. et al. Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation. Bone Marrow Transplant 39, 807–808 (2007). https://doi.org/10.1038/sj.bmt.1705679

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705679

  • Springer Nature Limited

This article is cited by

Navigation